These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28449776)

  • 1. Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.
    Lemesle G; Tricot O; Meurice T; Lallemant R; Delomez M; Equine O; Lamblin N; Bauters C
    J Am Coll Cardiol; 2017 May; 69(17):2149-2156. PubMed ID: 28449776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study).
    Hamon M; Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    JACC Cardiovasc Interv; 2018 May; 11(9):868-875. PubMed ID: 29747917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).
    Lemesle G; Lamblin N; Meurice T; Tricot O; Lallemant R; Nugue O; Delomez M; Equine O; Tondeux S; Bauters C
    Am Heart J; 2014 Oct; 168(4):479-86. PubMed ID: 25262257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis.
    Lamblin N; Meurice T; Tricot O; de Groote P; Lemesle G; Bauters C
    J Card Fail; 2018 Dec; 24(12):815-822. PubMed ID: 30296582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Lemesle G; Lamblin N; Schurtz G; Labreuche J; Duhamel A; Verdier B; Steg PG; Bauters C
    Circulation; 2024 May; 149(22):1708-1716. PubMed ID: 38660793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).
    Kimura T; Morimoto T; Kozuma K; Honda Y; Kume T; Aizawa T; Mitsudo K; Miyazaki S; Yamaguchi T; Hiyoshi E; Nishimura E; Isshiki T;
    Circulation; 2010 Jul; 122(1):52-61. PubMed ID: 20566955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: a report from the VA CART program.
    Armstrong EJ; Maddox TM; Carey EP; Grunwald GK; Shunk KA
    Am Heart J; 2014 Oct; 168(4):560-7. PubMed ID: 25262267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    Circ Cardiovasc Interv; 2015 Jul; 8(7):e002626. PubMed ID: 26156152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.
    Vink MA; Vos NS; Dirksen MT; Suttorp MJ; Slagboom T; Patterson MS; Kiemeneij F; Laarman G
    J Interv Cardiol; 2015 Dec; 28(6):523-30. PubMed ID: 26643000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.